PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 106 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 3.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $390,292 | -25.5% | 148,400 | 0.0% | 0.01% | -30.8% |
| Q2 2023 | $523,852 | +14.2% | 148,400 | 0.0% | 0.01% | +8.3% |
| Q1 2023 | $458,556 | -9.7% | 148,400 | +23.6% | 0.01% | -7.7% |
| Q4 2022 | $508,023 | +69.9% | 120,100 | -4.8% | 0.01% | +62.5% |
| Q3 2022 | $299,000 | -16.7% | 126,100 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $359,000 | -29.2% | 126,100 | -28.4% | 0.01% | -20.0% |
| Q1 2022 | $507,000 | -30.7% | 176,100 | -26.8% | 0.01% | -28.6% |
| Q4 2021 | $732,000 | – | 240,713 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |